Keith Loo is the CEO and Co-Founder of Skinopathy, an award-winning medical AI company developing advanced technologies for skin diseases and skin cancers. Skinopathy has won the 2022 INSEAD Business as a Force for Good Award, the 2023 First Prize for Innovation at the Canadian Society of Plastic Surgery Conference, 2024 Top 20 Early Tech Startup by the Canadian Innovation Exchange, and has been selected as the top startup to represent Canada at the Startup World Cup.

Keith has more than 20 years of technology experience working with firms such as Microsoft, Google, Logitech, and others, which has enabled him to consult for some of the world’s largest retailers, banks, and telcos on their Data & AI strategies and innovation labs.

Keith is also an instructor at the Schulich School of Business, York University, is a Special Advisor to the Executive Director of Innovation and Entrepreneurship, and is on the Advisory Committee for the MBA in Technology Leadership.